A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults

Condition:   Chronic Hepatitis C InfectionInterventions:   Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavrin;   Drug: Pegylated Interferon alpha 2-alpha (PegINF);   Drug: TelaprevirSponsor:   AbbVieActive, not recruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials